Your browser doesn't support javascript.
loading
Liver fibrosis for the dermatologist: a review.
Raahimi, Mina M; Livesey, Amy; Hamilton, Jessica; Shipman, Alexa R; Aspinall, Richard J.
Afiliación
  • Raahimi MM; Departments of Dermatology, Portsmouth Hospitals University NHS Trust, UK.
  • Livesey A; Departments of Dermatology, Portsmouth Hospitals University NHS Trust, UK.
  • Hamilton J; Departments of Dermatology, Portsmouth Hospitals University NHS Trust, UK.
  • Shipman AR; Departments of Dermatology, Portsmouth Hospitals University NHS Trust, UK.
  • Aspinall RJ; Departments of Gastroenterology and Hepatology, Portsmouth Hospitals University NHS Trust, UK.
Clin Exp Dermatol ; 48(4): 303-309, 2023 Mar 22.
Article en En | MEDLINE | ID: mdl-36763770
Methotrexate-induced liver fibrosis is not a well-defined pathology, and many of the reported cases can instead be classified as nonalcoholic fatty liver disease by current diagnostic criteria, which is particularly common in the psoriasis cohort. Liver fibrosis usually takes many years to progress; therefore, screening for liver fibrosis should be done no more regularly than annually at the very most in dermatology practice. An algorithm is presented about how to investigate abnormal liver blood tests and screening tools for liver fibrosis are compared.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Clin Exp Dermatol Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Clin Exp Dermatol Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido